EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of RUNX3 in Restriction Point Regulation

Jung-Won Lee iD, You-Soub Lee, Min-Kyu Kim, Xin-Zi Chi, Dohun Kim iD, Suk-Chul Bae

Cells · 2023

DOI: 10.3390/cells12050708 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Jung-Won Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Medicine and Institute for Tumour Research, Chungbuk National University, Cheongju 28644, Republic of Korea. Hauptthemen laut MEDLINE: Adenocarcinoma, Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation (NRF) of Korea, Basic Science Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A cell cycle is a series of events that takes place in a cell as it grows and divides. At the G1 phase of cell cycle, cells monitor their cumulative exposure to specific signals and make the critical decision to pass through the restriction (R)-point. The R-point decision-making machinery is fundamental to normal differentiation, apoptosis, and G1–S transition. Deregulation of this machinery is markedly associated with tumorigenesis. Therefore, identification of the molecular mechanisms that govern the R-point decision is one of the fundamental issues in tumor biology. RUNX3 is one of the genes frequently inactivated in tumors by epigenetic alterations. In particular, RUNX3 is downregulated in most K-RAS-activated human and mouse lung adenocarcinomas (ADCs). Targeted inactivation of Runx3 in the mouse lung induces adenomas (ADs), and markedly shortens the latency of ADC formation induced by oncogenic K-Ras. RUNX3 participates in the transient formation of R-point-associated activator (RPA-RX3-AC) complexes, which measure the duration of RAS signals and thereby protect cells against oncogenic RAS. This review focuses on the molecular mechanism by which the R-point participates in oncogenic surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaAdenocarcinoma of LungLung NeoplasmsAnimalsHumansMiceCell Transformation, NeoplasticCore Binding Factor Alpha 3 Subunit

Stichwörter der Autor:innen

K-RASR-pointRUNX3cell cycle

Substanzen

Core Binding Factor Alpha 3 SubunitRunx3 protein, human

Autor:innen und Institutionen

  • Department of Biochemistry, College of Medicine and Institute for Tumour Research, Chungbuk National University, Cheongju 28644, Republic of Korea.
  • Department of Thoracic and Cardiovascular Surgery, College of Medicine, Chungbuk National University, Cheongju 28644, Republic of Korea.

ORCID-Profile: Jung-Won Lee, Dohun Kim

Förderung

  • National Research Foundation (NRF) of Korea
  • Basic Science Research Program

Zitieren

APA

Lee, J. W., Lee, Y. S., Kim, M. K., Chi, X. Z., Kim, D., & Bae, S. C. (2023). Role of RUNX3 in Restriction Point Regulation. Cells. https://doi.org/10.3390/cells12050708

Vancouver

Lee JW, Lee YS, Kim MK, Chi XZ, Kim D, Bae SC. Role of RUNX3 in Restriction Point Regulation. Cells. 2023. doi:10.3390/cells12050708

BibTeX
@article{Lee2023,
  author = {Lee, Jung-Won and Lee, You-Soub and Kim, Min-Kyu and Chi, Xin-Zi and Kim, Dohun and Bae, Suk-Chul},
  title = {Role of RUNX3 in Restriction Point Regulation},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12050708}
}
Kostenlos starten →